IR(ME)R update 2021

24th September 2021  13:00 - 16:30 (GMT+01:00) Europe/London

Virtual event – Friday 24 September 13:00-16:30 BST
CPD: 4 credits 

Building on the success of previous BIR IR(ME)R updates, this half-day virtual event will cover both diagnostic radiology and radiotherapy issues. The emphasis this time is on governance, audit and managing patient dose. The multi-disciplinary emphasis and value of this event is maintained as we hear about the practical administration of non-medical referrers and the latest on a national IR(ME)R audit. You can also discover what plans are in place to learn from radiation incidents and the latest thinking on patient doses.

Educational aim: To provide an insight into the continued integration of the Ionising Radiation (Medical Exposure) Regulations, (IR(ME)R), into clinical practice and to discuss the potential impact of developments in dose and optimisation on patient management.

View the programme here

The session will be recorded if you are unable to attend on the day and will be available on-demand to those who have registered.

With sincere thanks to our sponsor:
PACSHealth specializes in radiology informatics with installs in 1200+ hospitals worldwide. Imaging technology solutions include PACSHealth®, VNAHealth®, DICOMeXtreme™ router, and DoseMonitor® – the top rated radiation dose management solution. 

EARLY BIRD Registration fees:
Non members £90
Plan 1 members £55
Plan 2/ Trainee/ International members £45
Retired/student member £35
*EARLY BIRD rates expire on Tuesday 24 August 2021

Registration fees:
Non members £95
Plan 1 members £60
Plan 2/ Trainee/ International members £50
Retired/student member £40

*VAT will be added at checkout, where applicable

Registration instructions
In order to register for this event you must first create a MyBIR portal. This is a free account with the BIR which will allow you to register for events and to retrieve receipts and CPD certificates. Once this is created, you can then register onto the event. If you have registered for a BIR event in the past you can login to your account first and then click on the register now button. You do not need to be a member of BIR or a radiologist to register for this event. All healthcare professionals are welcome. If you are having any issues registering please email

Payment for all events must be made via a debit or credit card. Invoices and PO numbers cannot be used for registration payment. If you need your hospital, Trust, or organisation to pay for registration fees please have them contact our events team at Please note VAT will be added for all virtual events to the registration fees listed. For any further inquiries please contact

If you are having issues registering for the event please create or login to your MyBIR account via this link and then register for the event after you have logged in. If you are still experiencing any issues please email




Advanced Accelerator Applications

Advanced Accelerator Applications, S.A. (AAA), a Novartis company, is an innovative medicines company developing targeted radioligand therapies and precision imaging radioligands for oncology. We are committed to transforming patients’ lives by leading innovation in nuclear medicine. AAA currently has over 1,000 employees working across 31 sites in 12 countries (Canada, France, Germany, Israel, Italy, the Netherlands, Poland, Portugal, Spain, Switzerland, the UK and the US). The company also has global manufacturing capabilities with 19 facilities in eight countries, and six research & development sites. For more information, please visit:

Bayer Healthcare

Bayer’s Radiology business is well placed to be the partner of choice in helping NHS trusts to address the many challenges faced today including the increasing need for governance to demonstrate best practice and improving patient care within increasing financial constraints. With market-leading contrast media and power injector systems, Bayer is able to offer innovative patient care and with the addition of its informatics platform, it can support radiology departments in driving protocol standardisation and easily accessible audit data that enable departments to meet further challenges faced around contrast and radiation dose management. 0118 2063999

GE Healthcare Ltd

GE Healthcare is a leading provider of medical imaging, monitoring, and life science technologies. GE Healthcare enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services to help providers, researchers and life sciences companies in their mission to improve outcomes for patients around the world.

PACSHealth – DoseMonitor

PACSHealth specializes in radiology informatics with installs in 1200+ hospitals worldwide. DoseMonitor® by PACSHealth is an automated, enterprise‐wise, patient radiation dose data management system. By managing radiation dose effectively, facilities can adapt to new technologies, manage risk, and meet evolving operations compliance requirements and regulatory standards such as IRMER 2017.

Philips Healthcare

Enabling better health and better care at lower cost Philips is a leading health technology company focused on improving people`s lives across the health continuum - from healthy living and prevention, to diagnosis, treatment and home care. Applying advanced technologies and deep clinical and consumer insights, Philips delivers integrated solutions that improve people`s health and enable better outcomes. Partnering with its customers, Philips seeks to transform how healthcare is delivered and experienced. The company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care.

Siemens Healthineers

Siemens Healthineers is shaping the future of Healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalising healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostics, image-guided therapy, and in-vivo diagnostics. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care to patients. For more information and latest product line visit